BeyondSpring is trading at $1.33 (7.6% down), extending a multi-day slide as the biotech sector faces broader pressure and profit-taking.
-
The move follows a brief rebound last week, though there is no fresh company-specific news, earnings, or regulatory updates tied to the stock today.
-
Broader market sentiment is weighing on high-beta names as investors rotate out of risk assets amid heightened geopolitical tensions and sector-wide volatility.